Transition Therapeutics Inc. Announces First Quarter Fiscal 2013 Financial Results

Published: Nov 09, 2012

TORONTO , Nov. 8, 2012 /CNW/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets, today announced its financial results for the three month period ended September 30, 2012 .

Back to news